Safety profile and medium- to long-term protection of the Recombinant Zoster Vaccine (RZV) in a cohort of high-risk patients: real-world data from a General Hospital in Southern Italy, 2021-2025.

Pasquale Stefanizzi, Lorenza Moscara, Claudia Palmieri, Andrea Martinelli, Antonio Di Lorenzo, Chiara Scaltrito, Petra Buonvino, Francesca Oliveto, Giovanna Pice, Laura Marchisella, Giuseppe Spinelli, Silvio Tafuri